Wells Fargo’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $460K | Buy |
|
|||||
|
2025
Q2 | $292K | Buy |
|
|||||
|
2025
Q1 | $53.8K | Buy |
|
|||||
|
2024
Q4 | $79.8K | Sell |
|
|||||
|
2024
Q3 | $167K | Buy |
|
|||||
|
2024
Q2 | $24.1K | Sell |
|
|||||
|
2024
Q1 | $56.4K | Buy |
|
|||||
|
2023
Q4 | $47.5K | Buy |
|
|||||
|
2023
Q3 | $59.1K | Sell |
|
|||||
|
2023
Q2 | $938K | Buy |
|
|||||
|
2023
Q1 | $936K | Buy |
|
|||||
|
2022
Q4 | $224K | Buy |
|
|||||
|
2022
Q3 | $224K | Sell |
|
|||||
|
2022
Q2 | $5.45M | Sell |
|
|||||
|
2022
Q1 | $11.9M | Sell |
|
|||||
|
2021
Q4 | $13.7M | Sell |
|
|||||
|
2021
Q3 | $20.9M | Buy |
|
|||||
|
2021
Q2 | $18.3M | Sell |
|
|||||
|
2021
Q1 | $42.9M | Buy |
|
|||||
|
2020
Q4 | $39.7M | Sell |
|
|||||
|
2020
Q3 | $62.8M | Buy |
|
|||||
|
2020
Q2 | $36.9M | Sell |
|
|||||
|
2020
Q1 | $27.1M | Buy |
|
|||||
|
2019
Q4 | $16.8M | Sell |
|
|||||
|
2019
Q3 | $17.3M | Sell |
|
|||||
|
2019
Q2 | $16.6M | Buy |
|
|||||
|
2019
Q1 | $7.92M | Buy |
|
|||||
|
2018
Q4 | $8.69M | Sell |
|
|||||
|
2018
Q3 | $9.68M | Buy |
|
|||||
|
2018
Q2 | $6.95M | Sell |
|
|||||
|
2018
Q1 | $7.76M | Buy |
|
|||||
|
2017
Q4 | $6.15M | Buy |
|
|||||
|
2017
Q3 | $3.69M | Buy |
|
|||||
|
2017
Q2 | $2.5M | Buy |
|
|||||
|
2017
Q1 | $2.14M | Sell |
|
|||||
|
2016
Q4 | $3.43M | Sell |
|
|||||
|
2016
Q3 | $7.92M | Buy |
|
|||||
|
2016
Q2 | $2.44M | Buy |
|
|||||
|
2016
Q1 | $2.86M | Buy |
|
|||||
|
2015
Q4 | $2.88M | Buy |
|
|||||
|
2015
Q3 | $1.6M | Buy |
|
|||||
|
2015
Q2 | $742K | Buy |
|
|||||
|
2015
Q1 | $356K | Sell |
|
|||||
|
2014
Q4 | $435K | Buy |
|
|||||
|
2014
Q3 | $340K | Sell |
|
|||||
|
2014
Q2 | $392K | Buy |
|
|||||
|
2014
Q1 | $388K | Buy |
|
|||||
|
2013
Q4 | $353K | Sell |
|
|||||
|
2013
Q3 | $294K | Buy |
|
|||||
|
2013
Q2 | $157K | Buy |
|